Table 7.
Description of the synthesis reagents.
| Components | Amount | Supplier | |
|---|---|---|---|
| A | [18F]F- | 12,690–30,600 MBq | Supplier 1 Supplier 2 |
| B | Kit reagent “Reagent for synthesis of [18F]F-PSMA-1007”: | ||
| PSMA-1007 precursor | 1.6 mg | ABX Advanced biochemical compounds | |
| DMSO for precursor | 2.2 ± 0.1 mL | ||
| Ethanol | 8 ± 0.3 mL | ||
| Phosphate buffered Saline | 15 ± 0.5 mL | ||
| 30% Ethanol solution | 8.5 ± 0.3 mL | ||
| Ethanol for Water bag | 5.7 ± 0.2 mL | ||
| Water for injections (B.Braun) | 100 mL ± 10% | ||
| Tetrabutylammonium Hydrogen Carbonate (0.075 M) | 750 ± 20 µL | ||
| C18ec cartridge Chromabond® (Macherey Nagel) | 1 | ||
| PS-H+ cartridge | 1 | ||
| Sep-PAK Light QMA cartridge | 1 | ||
| Syringe, 3 mL, empty, sterile (Becton Dickinson BD) | 1 | ||
| Syringe, 10 mL, empty, sterile (Becton Dickinson BD) | 1 | ||
| Cathivex-GV filter, 0.20 µm, PVDF, sterile (EMD Millipore) | 1 | ||
| MILLEX-25 filter 0.20 µm, sterile (EMD Millipore) | 1 | ||
| C | Cassette 18F-PSMA 1007 | 1 | TRASIS SA |